Jaehun Shin

Title: Jaehun Shin: Innovator in Anticancer Immunotherapy

Introduction

Jaehun Shin is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunotherapy, particularly in the development of innovative treatments for cancer. His work focuses on enhancing the therapeutic effects of T-cell therapy through genetic modifications.

Latest Patents

Jaehun Shin holds a patent for a "Mutant CTLA4 gene transfected T cell and composition including same for anticancer immunotherapy." This patent describes a transformed T-cell designed for T-cell therapy, characterized by the transfection of a gene coding for a chimera protein. The transformed T-cell aims to improve therapeutic effects by overcoming immune tolerance of cancer cells. Furthermore, it maximizes anti-cancer effects by activating signal transduction pathways that induce T-cell activation. This innovative approach also seeks to minimize side effects, such as the development of autoimmune diseases resulting from systemic T-cell activation. He has 1 patent to his name.

Career Highlights

Jaehun Shin is affiliated with the National Cancer Center, where he continues to advance his research in cancer immunotherapy. His work is pivotal in the ongoing efforts to develop effective treatments that harness the body's immune system to fight cancer.

Collaborations

Some of his notable coworkers include Kyungho Choi and Sang-Jin Lee, who contribute to the collaborative research environment at the National Cancer Center.

Conclusion

Jaehun Shin's innovative work in the field of anticancer immunotherapy exemplifies the potential of genetic engineering in enhancing T-cell therapies. His contributions are paving the way for more effective cancer treatments with reduced side effects.